Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - PacificHealth Labs., Inc. (NasdaqSC:PHLI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Recent Events
Aug 23Price hit new 52-week high ($8.38)
Location
1480 Route 9 North, Suite 204
Woodbridge, NJ 07095
Phone: (732) 636-6141
Fax: (732) 636-7410
Email: information@pacifichealthlabs.com
Employees (last reported count): 9
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 61%
·Institutional: 3% (9% of float)
(5 institutions)
·Net Inst. Buying: 186.0K shares (+48.56%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
PacificHealth Laboratories, Inc. was founded in 1995 to develop and commercialize nutritional products for sports nutrition, weight loss and Type 2 diabetes. The Company's first product is a dietary sports nutition supplement, Endurox. This was followed by Endurox R4 Performance/Recovery Drink using a patented ratio of carbohydrates to protein. The Company's newest product, Accelerade, is a sports drink to be used during exercise using the same Endurox R4 patented technology. The Company's weight loss product, Satietrol, stimulates the body's natural appetite control mechanism.
More from Market Guide: Expanded Business Description

Financial Summary
PacificHealth Laboratories, Inc. develops and commercializes nutritional products for sports nutrition, weight loss and Type two diabetes. For the six months ended 6/30/01, revenues totaled $4.5 million, up from $1.8 million. Net income totaled $1.2 million vs. a loss of $438 thousand. Revenues reflect increased product sales and the signing of a License Agreement with GSK. Earnings also benefitted from decreased clinical trial expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Robert Portman, Ph.D., 56
Chairman, Pres, CEO and Treasurer
$200K
Stephen Kuchen, 40
CFO, VP-Fin., Director
72K
David Portman, 60
Sec.
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:PHLIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Dec-2000
$0.25 
Recent Price$6.54 
52-Week High
on 23-Aug-2001
$8.38 
Beta2.12 
Daily Volume (3-month avg)74.4K
Daily Volume (10-day avg)138.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+207.8%
52-Week Change
relative to S&P500
+312.9%
Share-Related Items
Market Capitalization$38.2M
Shares Outstanding5.84M
Float2.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.84 
Earnings (ttm)$0.07 
Earnings (mrq)$0.24 
Sales (ttm)$1.29 
Cash (mrq)$0.33 
Valuation Ratios
Price/Book (mrq)7.74 
Price/Earnings (ttm)94.78 
Price/Sales (ttm)5.05 
Income Statements
Sales (ttm)$6.48M
EBITDA (ttm)$502.0K
Income available to common (ttm)$676.0K
Profitability
Profit Margin (ttm)10.4%
Operating Margin (ttm)7.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)21.16%
Return on Equity (ttm)26.68%
Financial Strength
Current Ratio (mrq)8.77 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$1.93M
Short Interest
As of 8-Aug-2001
Shares Short25.0K
Percent of Float1.1%
Shares Short
(Prior Month)
49.0K
Short Ratio0.41 
Daily Volume61.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.